Petco Health and Wellness Bolsa (NASDAQ: WOOF)

Últimas noticias sobre Petco Health and Wellness (NASDAQ:WOOF) Bolsa

Petco Health and Wellness

Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.

Petco Health and Wellness Company, Inc. - Class A Common Stock

Petco Health and Wellness Co Inc

WOOF

RBC Capital analyst Steven Shemesh reiterates Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and maintains $6 price target.

News

Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Outperform on Petco Health and Wellness, Maintains $6 Price Target

<h3>Gainers</h3>
<ul>
<li>Jeffs Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) stock increased by 38.6% to $3.19 during Friday's pre-market session. The company's market cap stands at $2.2 million. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) stock moved upwards by 22.44% to $6.0. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) shares rose 18.75% to $4.59. The market value of their outstanding shares is at $2.8 million. </li>
<li>American Outdoor Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) stock moved upwards by 12.01% to $12.21. The market value of their outstanding shares is at $156.7 million. The company's, Q2 earnings came out yesterday. </li>
<li>Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) shares moved upwards by 10.19% to $379.97. The market value of their outstanding shares is at $46.6 billion. The company's, Q3 earnings came out yesterday. </li>
<li>Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) stock increased by 9.17% to $22.01. The company's market cap stands at $421.3 million. As per the news, the Q3 earnings report came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Smith &amp; Wesson Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) stock declined by 16.7% to $11.35 during Friday's pre-market session. The company's market cap stands at $509.0 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) stock fell 15.89% to $5.4. The market value of their outstanding shares is at $624.3 million. </li>
<li>United Homes Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) stock fell 15.74% to $5.14. The company's market cap stands at $248.8 million. </li>
<li>EpicQuest Education Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEIQ#NASDAQ">EEIQ</a>) shares decreased by 8.92% to $0.92. The company's market cap stands at $11.9 million. </li>
<li>GigaCloud Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) shares declined by 8.7% to $22.15. The market value of their outstanding shares is at $907.5 million. </li>
<li>Shoe Carnival (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) shares fell 8.23% to $30.0. The market value of their outstanding shares is at $814.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AOUT

EEIQ

JFBR

LULU

SCVL

SWBI

SWIM

ZUMZ

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported better-than-expected results for its <a href="https://www.benzinga.com/quote/WOOF/earnings">third quarter on Thursday.</a>
The company posted a quarterly loss of 1 cents per share versus market estimates of a loss of 4 cents per share. The company reported quarterly sales of $1.51 billion which beat the analyst consensus estimate of $1.50 billion.
&#8220;Our third quarter results demonstrate the meaningful progress we&#8217;re making to strengthen our retail fundamentals to drive sustainable, profitable growth,&#8221; said Joel Anderson, Petco&#8217;s Chief Executive Officer. &#8220;While there is more work to do, our improving results increase our conviction that we are on the right path to position Petco to win long-term. Our entire organization is focused on driving profitability and free cash flow, and I&#8217;m confident we&#8217;re set up for a solid finish to 2024.&#8221;
Petco Health shares gained 16.9% to trade at $5.73 on Friday.
These analysts made changes to their price targets on Petco Health following earnings announcement.
<ul>
<li>Wells Fargo analyst Zachary Fadem maintained Petco Health and Wellness with an Equal-Weight and raised the price target from $3 to $5.</li>
<li>RBC Capital analyst Steven Shemesh maintained the stock with an Outperform and boosted the price target from $5 to $6.</li>
<li>Morgan Stanley analyst Simeon Gutman maintained Petco Health and Wellness with an Equal-Weight and raised the price target from $3 to $6.</li>
<li>Wedbush analyst Seth Basham maintained Petco Health and Wellness with an Outperform and boosted the price target from $5.5 to $6.</li>
</ul>
Considering buying WOOF stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="567" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-1024x567.png" alt="" class="wp-image-681107" style="width:571px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-1024x567.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454.png 1173w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42364367/how-to-earn-500-a-month-from-oracle-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Oracle Stock Ahead Of Q2 Earnings</a></li>
</ul>

Earnings

Markets

Trading Ideas

These Analysts Increase Their Forecasts On Petco Health and Wellness After Strong Q3 Results

Wedbush analyst Seth Basham maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and raises the price target from $5.5 to $6.

Wedbush Maintains Outperform on Petco Health and Wellness, Raises Price Target to $6

Morgan Stanley analyst Simeon Gutman maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and raises the price target from $3 to $6.

Morgan Stanley Maintains Equal-Weight on Petco Health and Wellness, Raises Price Target to $6

RBC Capital analyst Steven Shemesh maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and raises the price target from $5 to $6.

RBC Capital Maintains Outperform on Petco Health and Wellness, Raises Price Target to $6

WIIM

Petco Health shares are trading higher after Wells Fargo raised its price target on the stock from $3 to $5.

7 analysts have expressed a variety of opinions on Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $4.36, a high estimate of $5.50, and a low estimate of $3.00. Witnessing a positive shift, the current average has risen by 10.1% from the previous average price target of $3.96.
<img src="https://www.benzinga.com/files/images/story/2024/1733497339_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Petco Health and Wellness among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$5.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$5.50</td>
<td>$5.00</td>
</tr>
<tr>
<td>Steven Zaccone</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$4.50</td>
<td>$4.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$4.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$3.50</td>
<td>$3.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$3.00</td>
<td>$2.75</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Petco Health and Wellness. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Petco Health and Wellness compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Petco Health and Wellness's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Petco Health and Wellness's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WOOF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Petco Health and Wellness analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Petco Health and Wellness Better</h2>
Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.
<h3>Financial Milestones: Petco Health and Wellness's Journey</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Petco Health and Wellness's revenue growth over a period of 3 months has faced challenges. As of 31 July, 2024, the company experienced a revenue decline of approximately -0.46%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: Petco Health and Wellness's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -1.63%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Petco Health and Wellness's ROE stands out, surpassing industry averages. With an impressive ROE of -2.16%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.47%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 2.64, Petco Health and Wellness faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Ratings For Petco Health and Wellness

Wells Fargo analyst Zachary Fadem maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and raises the price target from $3 to $5.

Wells Fargo Maintains Equal-Weight on Petco Health and Wellness, Raises Price Target to $5

The earnings results for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:02 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Overview of Past Earnings</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness: Q3 Earnings Insights

Petco Health and Wellness shares are trading higher after the company announced better-than-expected Q3 financial results.

The Q3 earnings report for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
The company missed on EPS by $0.0 in the previous quarter, leading to a 33.0% increase share price change the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Summary: Petco Health and Wellness Q3

The Q3 earnings report for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Earnings History Overview</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness Q3 Earnings Assessment

Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) announced its Q3 earnings on Thursday, December 5, 2024 at 04:02 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Breakdown: Petco Health and Wellness Q3

The earnings results for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:02 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
The company missed on EPS by $0.0 in the previous quarter, leading to a 33.0% increase share price change the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness Earnings Review: Q3 Summary

Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported its Q3 earnings results on Thursday, December 5, 2024 at 04:02 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Overview of Past Earnings</h3>
During the previous quarter, the company missed on EPS by $0.0, leading to a 33.0% increase share price change the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Petco Health and Wellness Q3 Earnings

Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) just disclosed its Q3 earnings on Thursday, December 5, 2024 at 04:02 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Earnings History Overview</h3>
The company missed on EPS by $0.0 in the last quarter, resulting in a 33.0% increase share price change the following day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness Earnings Report: Q3 Overview

Fiscal Q4 2024 Outlook
The company is providing Q4 guidance for revenue, Adjusted EBITDA, and Adjusted EPS, in addition to full year interest expense and capital expenditure expectations.
For Fiscal Q4 2024, the company expects:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Metric&#x2A;</td>
<td colspan="1" rowspan="1">
FQ4 2024
Guidance
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Revenue</td>
<td colspan="1" rowspan="1">~ $1.55 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">Between $90 million and $95 million, including a minimum of $10 million in third party consulting fees associated with our transformation effort</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EPS</td>
<td colspan="1" rowspan="1">Between $0.00 and $0.02</td>
</tr>
</tbody>
</table>
</figure>
For Fiscal 2024 (a 52-week year), the company expects the following:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Metric&#x2A;</td>
<td colspan="1" rowspan="1">
2024
Guidance, YoY
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net interest expense</td>
<td colspan="1" rowspan="1">~$140 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital Expenditures</td>
<td colspan="1" rowspan="1">~$130 million</td>
</tr>
</tbody>
</table>
</figure>
&#x2A;Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. For fiscal 2024, our guidance anticipates a 26 percent tax rate, and 273 million weighted average diluted share count. Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

Guidance

Petco Health and Wellness Company Sees Q4 Adj EPS $0.00-$0.02 Vs $0.04 Est.; Revenue ~$1.55B Vs $1.57B Est.

Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 60 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $1.51 billion which beat the analyst consensus estimate of $1.50 billion by 0.76 percent. This is a 1.17 percent increase over sales of $1.49 billion the same period last year.

Earnings Beats

Petco Health and Wellness Q3 Adj $(0.02) Beats $(0.04) Estimate, Sales $1.51B Beat $1.50B Estimate

<h3>Companies Reporting Before The Bell</h3>
• John Wiley &amp; Sons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLY#NYSE">WLY</a>) is likely to report quarterly earnings at $0.70 per share on revenue of $420.00 million. 
• America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) is projected to report quarterly loss at $0.10 per share on revenue of $344.37 million. 
• Science Applications Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) is expected to report quarterly earnings at $2.16 per share on revenue of $1.93 billion. 
• Patterson Cos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDCO#NASDAQ">PDCO</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $1.65 billion. 
• Methode Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEI#NYSE">MEI</a>) is estimated to report quarterly loss at $0.16 per share on revenue of $268.46 million. 
• Signet Jewelers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) is projected to report quarterly earnings at $0.33 per share on revenue of $1.37 billion. 
• Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) is estimated to report quarterly earnings at $0.94 per share on revenue of $10.14 billion. 
• Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>) is projected to report quarterly earnings at $1.21 per share on revenue of $675.35 million. 
• Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $187.70 million. 
• Lands' End (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LE#NASDAQ">LE</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $315.21 million. 
• Hooker Furnishings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFT#NASDAQ">HOFT</a>) is projected to report quarterly earnings at $0.28 per share on revenue of $101.35 million. 
• Toronto-Dominion Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TD#NYSE">TD</a>) is likely to report quarterly earnings at $1.28 per share on revenue of $10.26 billion. 
• GMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) is projected to report quarterly earnings at $2.19 per share on revenue of $1.46 billion. 
• Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) is expected to report quarterly loss at $0.12 per share on revenue of $1.71 billion. 
• Duluth Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTH#NASDAQ">DLTH</a>) is expected to report quarterly loss at $0.32 per share on revenue of $134.93 million. 
• Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) is projected to report quarterly earnings at $0.98 per share on revenue of $34.20 billion. 
• Canadian Imperial Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CM#NYSE">CM</a>) is likely to report quarterly earnings at $1.26 per share on revenue of $4.67 billion. 
• Caleres (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAL#NYSE">CAL</a>) is estimated to report quarterly earnings at $1.36 per share on revenue of $751.36 million. 
• Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) is likely to report quarterly earnings at $1.73 per share on revenue of $5.98 billion. 
• Brown Forman Inc Class B Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $1.07 billion. 
• John Wiley &amp; Sons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLYB#NYSE">WLYB</a>) is expected to report earnings for its second quarter. 
• Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $113.40 million. 
• Tuniu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOUR#NASDAQ">TOUR</a>) is likely to report earnings for its third quarter. 
• Brown Forman Inc Class A Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is projected to report earnings for its second quarter. 
<h3>Companies Reporting After The Bell</h3>
• Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) is likely to report quarterly earnings at $0.30 per share on revenue of $253.96 million. 
• Victoria's Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) is likely to report quarterly loss at $0.62 per share on revenue of $1.29 billion. 
• UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $347.72 million. 
• Smith &amp; Wesson Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $133.52 million. 
• Asana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) is expected to report quarterly loss at $0.07 per share on revenue of $180.66 million. 
• Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $222.04 million. 
• Domo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOMO#NASDAQ">DOMO</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $77.55 million. 
• Lakeland Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAKE#NASDAQ">LAKE</a>) is likely to report quarterly earnings at $0.40 per share on revenue of $44.30 million. 
• Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) is estimated to report quarterly earnings at $1.26 per share on revenue of $225.60 million. 
• Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) is expected to report quarterly earnings at $2.72 per share on revenue of $2.36 billion. 
• Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) is likely to report quarterly earnings at $1.58 per share on revenue of $684.34 million. 
• Smartsheet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) is likely to report quarterly earnings at $0.30 per share on revenue of $283.87 million. 
• GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $188.25 million. 
• HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $163.39 million. 
• Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) is likely to report quarterly loss at $0.32 per share on revenue of $140.84 million. 
• Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) is projected to report quarterly earnings at $4.52 per share on revenue of $2.50 billion. 
• Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) is likely to report quarterly loss at $0.40 per share on revenue of $217.53 million. 
• Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) is projected to report quarterly loss at $0.03 per share on revenue of $1.50 billion. 
• Samsara (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $310.56 million. 
• DocuSign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) is expected to report quarterly earnings at $0.87 per share on revenue of $745.26 million. 
• American Outdoor Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) is projected to report quarterly earnings at $0.20 per share on revenue of $53.23 million. 
• Hewlett Packard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) is likely to report quarterly earnings at $0.56 per share on revenue of $8.26 billion. 
• Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) is likely to report quarterly earnings at $1.00 per share on revenue of $1.03 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASAN

CRMT

CSIQ

DLTH

DOCU

DOMO

GTLB

GWRE

HOFT

LAKE

PATH

PDCO

RBRK

SAIC

SMAR

TLYS

TOUR

ULTA

VEEV

VSCO

WLYB

Earnings Scheduled For December 5, 2024

Wedbush analyst Seth Basham raised the firm's price target on Petco (WOOF) to $6 from $5.50 and keeps an Outperform rating on the shares. Petco's Q...

Petco price target raised to $6 from $5.50 at Wedbush

RBC Capital raised the firm's price target on Petco (WOOF) to $6 from $5 and keeps an Outperform rating on the shares. The company reported another...

Petco price target raised to $6 from $5 at RBC Capital

Evercore ISI raised the firm's price target on Petco (WOOF) to $6 from $5 and keeps an In Line rating on the shares. The company's Q3 results were ...

Petco price target raised to $6 from $5 at Evercore ISI

Evercore ISI analyst Oliver Wintermantel has maintained their neutral stance on WOOF stock, giving a Hold rating today. Oliver Wintermantel's ratin...

Petco's Mixed Performance: Strong Q3 with Growth in Veterinary Services Amid Ongoing Challenges

The Gabelli Pet Parents' Fund Q3 2024 Commentary

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Tesla (TSLA – Research Report), Petco Healt...

Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: Tesla (TSLA), Petco Health and Wellness Company (WOOF) and Mission Produce (AVO)

The retail market is attractive due to expanding demand across various sectors, increased consumer spending, technological advancements, and a favorable economic environment fostering growth opportunities, making innovative retail stocks like Petco Health and Wellness Company (WOOF), Chewy (CHWY), and Levi Strauss (LEVI), which are adapting to new consumer trends, worth considering. Read on... The retail sector is expanding with innovations in social commerce, AI, personalization, and automation, driving improved outcomes. Consumer spending has increased on goods like apparel and essentials, as well as pet care. In this favorable landscape, investors could consider innovative retail stocks like Petco Health and Wellness Company, Inc. (<a href="https://stocknews.com/stock/WOOF/">WOOF</a>), Chewy, Inc. (<a href="https://stocknews.com/stock/CHWY/">CHWY</a>), and Levi Strauss &amp; Co. (<a href="https://stocknews.com/stock/LEVI/">LEVI</a>).
The retail sector, adapting to new consumer trends, offers stable investment potential, as consumer goods companies typically see consistent demand. With the U.S. Federal Reserve cutting interest rates by <a href="https://www.reuters.com/markets/rates-bonds/view-fed-cuts-25-bp-scales-back-2025-easing-projections-2024-12-18/">25 basis points</a> to 4.3% - 4.5% in December and projecting two more cuts by the end of 2025, the favorable economic environment presents an opportune time to invest in the sector as demand rises.
Consequently, the consumer goods market is projected to reach $2.80 trillion in 2024, with an expected <a href="https://www.statista.com/outlook/io/manufacturing/consumer-goods/worldwide">CAGR of 1.2%</a> from 2024 to 2029. Notably, the ever-evolving trends of the apparel sector benefit the consumer goods industry by driving online sales growth, influencing digital innovation, and enhancing customer experiences through personalized services, especially during the holidays now.
Further, the retail sector benefits from increased pet ownership, which has fueled demand for pet products and services. Retail innovations like auto-ship subscriptions and discounts are boosting sales, while growing interest in high-quality, health-focused pet foods is reshaping the market. The pet services market is projected to grow at a <a href="https://www.globenewswire.com/news-release/2024/11/27/2988366/28124/en/Pet-Services-Market-Forecast-by-Pet-Services-Service-Delivery-Channel-and-Region-2025-2030.html">CAGR of 11.7%</a>, reaching $63.96 billion by 2030.
Considering these conducive trends, let's analyze the fundamental aspects of the three <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> picks, beginning with the third choice.
Stock #3: Petco Health and Wellness Company, Inc. (<a href="https://stocknews.com/stock/WOOF/">WOOF</a>)
WOOF operates as a health and wellness company, focusing on enhancing the lives of pets, pet parents, and its Petco partners in the United States, Mexico, and Puerto Rico. The company provides veterinary care, grooming, training, telehealth, Vital Care, and pet health insurance services, as well as veterinary services through Vetco mobile clinics.
In terms of the trailing-12-month <a href="https://www.investopedia.com/terms/a/assetturnover.asp">asset turnover ratio</a>, WOOF's 1.17x is 19% higher than the industry average of 0.99x.
In the third quarter that ended November 2, 2024, WOOF's total net sales grew 1.2% from the year-ago value to $1.51 billion. The company's gross profit came in at $575.76 million, up 4.6% year-over-year. Furthermore, its adjusted EBITDA rose 12.6% from the prior year's quarter to $81.24 million.
Analysts expect WOOF's revenue for the quarter ending April 30, 2025, to increase 2% year-over-year to $1.56 billion. It surpassed the consensus EPS estimates in each of the trailing four quarters. WOOF's stock has gained 100% over the past nine months to close the last trading session at $3.96.
WOOF's robust outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. It has an overall rating of B, equating to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
It has a B grade for Growth and Quality. Within the <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> industry, it is ranked #16 out of 55 stocks. To access WOOF's grades for Value, Momentum, Stability, and Sentiment, <a href="https://stocknews.com/stock/WOOF/">click here</a>.
Stock #2: Chewy, Inc. (<a href="https://stocknews.com/stock/CHWY/">CHWY</a>)
CHWY engages in the pure-play e-commerce business in the United States. It provides pet food, treats, pet supplies, pet medications, and other pet health products, as well as pet services for dogs, cats, fish, birds, small pets, horses, and reptiles through its retail websites and mobile applications.
In terms of the trailing-12-month Return on Common Equity, CHWY's 130.34% is considerably higher than the 11.03% industry average. Its 13.59% trailing-12-month Return on Total Assets is 245.2% higher than the 3.94% industry average. Additionally, its 3.88x trailing-12-month asset turnover ratio is 298.8% higher than the 0.99x industry average.
CHWY's net sales for the third quarter ended October 27, 2024, increased 4.8% year-over-year to $2.88 billion. The company's gross profit rose 7.9% compared to the prior-year quarter, reaching $843.87 million. Additionally, its adjusted net income and adjusted EPS increased 33.8% and 33.3%, respectively, from the year-ago values, to $84.92 million and $0.20.
For the quarter ending January 31, 2025, CHWY's EPS is expected to grow 10.4% year-over-year to $0.20. Its revenue for the same quarter is expected to rise 12.8% year-over-year to $3.19 billion. It surpassed the Street EPS estimates in three of the trailing four quarters. Over the past nine months, the stock has gained 90.1% to close the last trading session at $33.72.
CHWY's strong fundamentals are reflected in its POWR Ratings. It has an overall rating of B, equating to a Buy in our proprietary rating system.
It has a B grade for Quality. It is ranked #13 in the same industry. To see CHWY's Growth, Value, Momentum, Stability, and Sentiment ratings, <a href="https://stocknews.com/stock/CHWY/">click here</a>.
Stock #1: Levi Strauss &amp; Co. (<a href="https://stocknews.com/stock/LEVI/">LEVI</a>)
LEVI designs, markets, and sells apparel and related accessories for men, women, and children worldwide. The company offers jeans, casual and dress pants, activewear, tops, shorts, skirts, dresses, jumpsuits, shirts, sweaters, jackets, footwear, and related accessories under the Levi's, Dockers, Signature by Levi Strauss &amp; Co., Denizen, and Beyond Yoga brands.
On October 11, 2024, LEVI's Beyond Yoga launched Club Beyond, a weeklong pop-up in New York City featuring fitness classes, wellness workshops, exclusive retail, and customization experiences. The event aims to expand its customer base, deepen engagement, and highlight the brand's pillars: mind, body, and connection.
In terms of the trailing-12-month EBIT margin, LEVI's 9.36% is 16.5% higher than the 8.03% industry average. Likewise, its 9.98% trailing-12-month levered FCF margin is 124.1% higher than the 4.45% industry average. Furthermore, the stock's 8.82% trailing-12-month Return on Total Capital is 41.8% higher than the 6.22% industry average.
During the fiscal third quarter that ended August 25, 2024, LEVI's net revenues increased marginally year-over-year to $1.52 billion. Similarly, its operating income stood at $30.30 million. For the same period, the company's adjusted EBITDA rose 25.6% from the year-ago value to $225.30 million.
Street expects LEVI's EPS and revenue for the quarter ending November 30, 2024, to increase 9.2% and 5.2% year-over-year to $0.48 and $1.74 billion, respectively. It surpassed the Street EPS estimates in each of the trailing four quarters. LEVI's stock has gained 12.9% over the past year to close the last trading session at $17.39.
LEVI's solid prospects are reflected in its POWR Ratings. It has an overall rating of B, translating to a Buy in our proprietary rating system.
It has a B grade for Growth, Sentiment, and Quality. It is ranked #2 in the Consumer Goods industry. Beyond what we stated above, we also have given LEVI grades for Value, Momentum, and Stability. Get all the LEVI's ratings <a href="https://stocknews.com/stock/LEVI/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
CHWY shares were trading at $34.77 per share on Monday afternoon, up $1.05 (+3.11%). Year-to-date, CHWY has gained 47.14%, versus a 26.33% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Abhishek Bhuyan</h2> <img src='https:/wp-content/uploads/2023/07/ABhuyan.jpg' style="float:left; padding:5px;width:125px;">Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.<a href="https://stocknews.com/authors/?author=abhishek-bhuyan">More...</a>The post <a href=https://stocknews.com/news/chwy-levi-woof-3-innovative-retail-stocks-adapting-to-new-consumer-trends/>3 Innovative Retail Stocks Adapting to New Consumer Trends</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Innovative Retail Stocks Adapting to New Consumer Trends

Petco: A Bone To Pick With High Debt For This Difficult Turnaround

Wedbush analyst Seth Basham maintained a Buy rating on Petco Health and Wellness Company (WOOF – Research Report) today and set a price target of $...

Wedbush Remains a Buy on Petco Health and Wellness Company (WOOF)

CHWY

LEVI

PAWZ

TRUP

TSLA

Press Releases

Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS

Legal

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Petco Health and Wellness Company, Inc. - WOOF

Petco Health and Wellness Company, Inc. Investors: Company Investigated by the Portnoy Law Firm

Petco Names Joel D. Anderson as Chief Executive Officer

Petco Health + Wellness Company, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Petco Health and Wellness Company, Inc. to Host Second Quarter 2024 Earnings Conference Call on September 10, 2024

Petco Health + Wellness Company, Inc. Reports Second Quarter 2024 Earnings Results

Petco Health and Wellness Company, Inc. to Host Third Quarter 2024 Earnings Conference Call on December 5, 2024

Petco Names Joe Venezia Chief Revenue Officer

Petco Health + Wellness Company, Inc. Reports Third Quarter 2024 Earnings Results

DYAI

VTAK

Academy Sports and Outdoors, Inc. - Common Stock

Academy Sports

BARK

Build-A-Bear Workshop

Bath & Body Works

Barnes & Noble Education, Inc Common Stock

Barnes & Noble Education

Chewy

Dick's Sporting Goods

Envela

National Vision Holdings, Inc. - Common Stock

National Vision Holdings

Five Below

1-800-FLOWERS.COM, Inc. - Class A Common Stock

1-800-Flowers.com

Fitell

MarineMax

Leslies

PetMed Express

Park Ha Biological Technology Co., Ltd. - ordinary shares

Park Ha Biological Tech

Sally Beauty Holdings, Inc. (Name to be changed from Sally Holdings, Inc.) Common Stock

Comments

Petco Health and Wellness

Noticias

Últimas noticias sobre Petco Health and Wellness (NASDAQ:WOOF) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL